WO2003000718A3 - Nouveau peptide et son utilisation - Google Patents

Nouveau peptide et son utilisation Download PDF

Info

Publication number
WO2003000718A3
WO2003000718A3 PCT/JP2001/008221 JP0108221W WO03000718A3 WO 2003000718 A3 WO2003000718 A3 WO 2003000718A3 JP 0108221 W JP0108221 W JP 0108221W WO 03000718 A3 WO03000718 A3 WO 03000718A3
Authority
WO
WIPO (PCT)
Prior art keywords
fodrin
sjögren
polypeptides
syndrome
alpha
Prior art date
Application number
PCT/JP2001/008221
Other languages
English (en)
Other versions
WO2003000718A2 (fr
Inventor
Yoshio Hayashi
Original Assignee
Yoshio Hayashi
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshio Hayashi, Fujisawa Pharmaceutical Co filed Critical Yoshio Hayashi
Priority to AU2001288087A priority Critical patent/AU2001288087A1/en
Publication of WO2003000718A2 publication Critical patent/WO2003000718A2/fr
Publication of WO2003000718A3 publication Critical patent/WO2003000718A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un polypeptide constitué d'une séquence partielle d'acides aminés de α-fodrine renfermant une séquence d'acides aminés décrite dans SEQ ID No:1, SEQ ID No:2 ou SEQ ID No:4, son mutant, et en particulier un analogue épitope analogue contenant une séquence décrite dans SEQ ID No:3, ainsi que leur utilisation.
PCT/JP2001/008221 2001-06-22 2001-09-21 Nouveau peptide et son utilisation WO2003000718A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288087A AU2001288087A1 (en) 2001-06-22 2001-09-21 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR5897A AUPR589701A0 (en) 2001-06-22 2001-06-22 Novel peptide and use thereof
AUPR5897 2001-06-22

Publications (2)

Publication Number Publication Date
WO2003000718A2 WO2003000718A2 (fr) 2003-01-03
WO2003000718A3 true WO2003000718A3 (fr) 2003-08-21

Family

ID=3829866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/008221 WO2003000718A2 (fr) 2001-06-22 2001-09-21 Nouveau peptide et son utilisation

Country Status (2)

Country Link
AU (2) AUPR589701A0 (fr)
WO (1) WO2003000718A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100572391C (zh) * 2006-08-30 2009-12-23 中国科学院广州生物医药与健康研究院 β-胞衬蛋白抗原表位多肽及其筛选方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188816A1 (fr) * 1996-04-23 1997-10-24 Takeda Chemical Industries, Ltd. Composition renfermant de l'o-fodrine ou un fragment proteinique d'o-fodrine
JPH10251157A (ja) * 1996-04-23 1998-09-22 Yoshio Hayashi α−フォドリンまたはα−フォドリン断片蛋白質を含む剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188816A1 (fr) * 1996-04-23 1997-10-24 Takeda Chemical Industries, Ltd. Composition renfermant de l'o-fodrine ou un fragment proteinique d'o-fodrine
JPH10251157A (ja) * 1996-04-23 1998-09-22 Yoshio Hayashi α−フォドリンまたはα−フォドリン断片蛋白質を含む剤

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199820, Derwent World Patents Index; Class B04, AN 1998-217935, XP002223821 *
HANEJI N ET AL: "Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.", SCIENCE. UNITED STATES 25 APR 1997, vol. 276, no. 5312, 25 April 1997 (1997-04-25), pages 604 - 607, XP002223818, ISSN: 0036-8075 *
ISHIMARU N ET AL: "Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.", AMERICAN JOURNAL OF PATHOLOGY. UNITED STATES MAY 2000, vol. 156, no. 5, May 2000 (2000-05-01), pages 1557 - 1564, XP002223819, ISSN: 0002-9440 *
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 14 31 December 1998 (1998-12-31) *
SAEGUSA K ET AL: "Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.", SCANDINAVIAN JOURNAL OF IMMUNOLOGY. ENGLAND SEP 2000, vol. 52, no. 3, September 2000 (2000-09-01), pages 264 - 270, XP002223820, ISSN: 0300-9475 *

Also Published As

Publication number Publication date
AU2001288087A1 (en) 2003-01-08
AUPR589701A0 (en) 2001-07-19
WO2003000718A2 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
AUPP051497A0 (en) Antimicrobial peptides
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
WO2004043382A3 (fr) Variants ameliores de l'erythropoietine et methodes d'utilisation
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
EP2360259A3 (fr) Peptides de la promyostatine et procedes d'utilisation de ces derniers
MXPA04000597A (es) Peptidos novedosos de la proteina g del virus sincicial respiratorio (rsv), y su uso en una vacuna.
WO2005051998A3 (fr) Anticorps
MX9503362A (es) Nuevos anticuerpos br96 mutantes y equivalentes funcionales que reaccionan con carcinomas humanos.
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
WO2003031598A3 (fr) Sequences d'acides nucleiques et d'acides amines codant des polypeptides de facteur viii a expresseur a haut rendement et leurs procedes d'utilisation
WO2002008426A3 (fr) Proteine
WO2006090090A3 (fr) Epitopes de vih et composition pharmaceutique les contenant
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
WO2000058465A3 (fr) Analogues polypeptidiques de flint
WO2003000718A3 (fr) Nouveau peptide et son utilisation
EP1251176A3 (fr) Systèmes d' expression utilisant des protéines de fusion autolytiques et un polypeptide réducteur
WO2003095493A3 (fr) Polypeptides apparentes aux toxines presentant une activite antimicrobienne et antivirale
WO2001011937A3 (fr) Utilisation de la colostrinine, de ses peptides constitutifs et de ses analogues pour activer des cytokines
WO1997039029A3 (fr) Epitope antigenique du determinant a de l'antigene de surface de l'hepatite b et ses utilisations
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
WO2002030975A3 (fr) Composé fongicide
WO2001098355A3 (fr) Compositions cgi-69 et procedes d'utilisation
PT1847607E (pt) Anticorpos contra a proteína p51
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
WO2004000870A3 (fr) Deux peptides synthetiques pour le traitement et la prevention de cancers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP